Abreu, Eliabe S.
Reginato, Pedro Henrique
Pitanga, Jorge Ferreira Jasmineiro
Borges, Pedro Neves
Soret, Pierre-Antoine
Corpechot, Christophe
Cançado, Guilherme Grossi Lopes
Article History
Received: 26 November 2024
Accepted: 3 April 2025
First Online: 19 April 2025
Declarations
:
: Dr. Corpechot reports receiving research grants from Arrow and Intercept France, consulting fees from Intercept France, Advanz, Cymabay, Ipsen, Genkyotex, GlaxoSmithKline France, and Inventiva Pharma, and speaker fees from Intercept France, Echosens, Gilead and GlaxoSmithKline France. Dr. Cançado reports receiving a research grant from IPSEN.